Navigation Links
Royalty Rates Take Center Stage in Biopharma Dealmaking
Date:11/14/2012

ATLANTA, Nov. 14, 2012 /PRNewswire-USNewswire/ -- One-by-one, big pharmaceutical firms are plunging off patent cliffs. They're scrambling to fill pipelines and reinforce bottom lines. The door is open wider than ever for biotechnology companies and their coffers of innovative therapeutic candidates to negotiate lucrative licensing deals with a focus on royalty rates. New data from BioWorld reveal that biotechs can garner higher rates from a pharma partner than any other licensee.

(Logo:  http://photos.prnewswire.com/prnh/20120628/DC32901LOGO)

The average royalty rate for deals with a pharma licensee is 14.9% at the high end and 11.74% at the low end, while other deals (ex: other biotechs) command average royalty rates between 9.88% and 6.39%, according to Biopharmaceutical Royalty Rates Analysis: Essential Benchmarks for Dealmaking, a new BioWorld Data tool that analyzes hundreds of licensing deals to provide a tangible starting point for deal negotiations.

Drugs to treat pain are garnering the highest average royalty rate of 14.7% at the high end and 8.5% at the low end.

"Just last month, on the eve of reporting 3Q earnings, Eli Lilly and Co.'s Fitch Rating was lowered from stable to negative due to Lilly's looming patent cliff, called the steepest in the industry by Fitch, due to anticipated losses of antidepressant Cymbalta and Type I diabetes drug Humalog next year," said Lynn Yoffee, BioWorld's executive editor. "Partnering and dealmaking are a matter of survival. The extra tough economy has forced drug developers to sharpen their dealmaking skills. To help drugmakers at the negotiating table, we've analyzed >300 licensing deals to provide an array of average and median royalty rates and up-front licensing fees to help these negotiators with details that can be used as benchmarks and comparators."

The report includes a variety of analyses, including a deeper dive into certain hot disease areas such as Alzheimer's and hepatitis. Backing up the analyses are profiles of more than 320 deals including all deal terms and key background information on the drug or drug technology in focus.

For access to BioWorld's Biopharmaceutical Royalty Rates Analysis: Essential Benchmarks for Dealmaking visit www.bioworld.com/royaltyrates or call 800-888-3912.

BioWorld Today, and its analytical companion, BioWorld Insight, are the biopharmaceutical industry's most respected news sources and have been for more than two decades. All of that information is now leveraged in BioWorld Data, business intelligence for biopharmaceutical executives.

CONTACT: Lynn Yoffee, Executive Editor, +1-404-262-5408


'/>"/>
SOURCE BioWorld
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
2. Henry Schein Celebrates Earth Day
3. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
4. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
5. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
6. Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant
7. AXIOS™ Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis
8. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
9. Liberty Dialysis Celebrates Milestone 1,000th Patient in Peritoneal Dialysis Program
10. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
11. BIOCRATES Life Sciences to Launch Waters Xevo® TQ MS Editions for Two of its Well-established Research Kit Products, AbsoluteIDQ® p180 and p150
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , April 24, 2017 SW Safety ... protection, and comfort, announces the release of the latest ... This most recent example of leading edge nitrile glove ... pattern for 200% more tactile grip on wet and ... and durability. With TracTek and a suite of other ...
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... 20, 2017 Research and Markets ... Pipeline and Market Prospects: Addressing Production Complexities Through Risk ... offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities ... in-depth assessment of the current trends in the global ...
Breaking Medicine Technology:
(Date:4/29/2017)... ... 29, 2017 , ... Sterling Global Products is pleased to ... biodegradable, hanging flushable wipes dispensers and/or 42 count refill packs manufactured by this ... Texas, operates more than 350 stores throughout Texas and expanding into northern Mexico ...
(Date:4/29/2017)... ... 29, 2017 , ... Saturday, April 29, marks World Veterinary ... have on animal health and welfare as well as on public health. The ... a theme each year and this year have selected “Antimicrobial Resistance—From Awareness to ...
(Date:4/28/2017)... ... 2017 , ... The National Campaign to Prevent Teen ... to Contraception for Women Servicemembers and Dependents Act of 2017. The bill, introduced ... to ensure that all members of the Armed Forces receive high quality education ...
(Date:4/28/2017)... ... 28, 2017 , ... It's not always common knowledge whether or not a ... unclear as to whether or not they are contagious, and most people don't know ... So, FindaTopDoc took a look into the matter. , They discovered that the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Beginning in 2017, Ridgecrest ... formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure that the ... formula in the following ways:, , Removal of the homeopathic ...
Breaking Medicine News(10 mins):